Up until a few years ago FDA required pharmaceutical companies to duplicate the same studies that were required in adults in children. This requirement often prevented development in children because of time, money, and difficulty in running these studies in children. In 2002 and 2003 Congress enacted laws that allowed pharmaceutical companies to utilize existing adult data to support a pediatric program. During the following two years 70 drugs for adults received approval for a pediatric indication. In 2012 Congress followed up with a law that applied what had been learned following 2003.

Date : 29th July 2015 to 29th July 2015

Place : United States, New hyde park

Website :https://www.complianceglobal.us/product/700124

Contact Person:Compliance Global Inc.

Description:

Up until a few years ago FDA required pharmaceutical companies to duplicate the same studies that were required in adults in children. This requirement often prevented development in children because of time, money, and difficulty in running these studies in children. In 2002 and 2003 Congress enacted laws that allowed pharmaceutical companies to utilize existing adult data to support a pediatric program. During the following two years 70 drugs for adults received approval for a pediatric indication. In 2012 Congress followed up with a law that applied what had been learned following 2003.

Up until a few years ago FDA required pharmaceutical companies to duplicate the same studies that were required in adults in children. This requirement often prevented development in children because of time, money, and difficulty in running these studies in children. In 2002 and 2003 Congress enacted laws that allowed pharmaceutical companies to utilize existing adult data to support a pediatric program. During the following two years 70 drugs for adults received approval for a pediatric indication. In 2012 Congress followed up with a law that applied what had been learned following 2003. will be held in New hyde park,United States on date 2015-07-29

---

Deadline for abstracts/proposals : 29th July 2015

Keynote Speakers : Robert L. Kunka, Ph. D. is an accomplished and respected scientist who contributed to the development of 28 approved pharmaceutical products in eight therapeutic areas. His expertise on international product development teams produced submissions with successful clinical strategies, sound matrix management of individual study teams, and effective interactions with regulatory agencies leading to successful IND, aNDA, and NDA approvals. Bob’s experience in drug development stems from 24 years in

Conference Highlights :Compliance Global Inc; is a training organization based in New Hyde Park, New York, providing world-class compliance trainings by leveraging a pool of experienced speakers / consultants in the Pharmaceutical, Bio-Technology, Medical Devices, Clinical Compliance, FDA Compliance, Healthcare, BFSI & HR streams for improving the knowledge base of the customers. These trainings are contemporary, simple and cost-effective with easy access and great delivery experience. Compliance Global is a multi

Venue :Online Training Compliance Global Inc. 2754 80th Avenue, New Hyde Park, NY 11040 Email: [email protected] Toll Free: +1-844-746-4244 Tel: +1-516-900-5515

Check the event website for more details.